首页/数据集/Additional file 1 of Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection

Additional file 1 of Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection

NIAID Data Ecosystem2026-05-01 收录

黏膜疫苗研发

幽门螺杆菌免疫防治

数据链接：

https://figshare.com/articles/dataset/Additional_file_1_of_Recombinant_L_lactis_vaccine_LL-plSAM-WAE_targeting_four_virulence_factors_provides_mucosal_immunity_against_H_pylori_infection/25284826 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Material 1

应用场景：

创建时间：

2024-02-24

训练免疫机制

黏膜疫苗研发

MV130 is an inactivated polybacterial mucosal vaccine that confers protection to patients against recurrent respiratory infections, including those of viral etiology. However, its mechanism of action

NIAID Data Ecosystem40

DataSheet_1_Surface Display of porcine circovirus type 2 antigen protein cap on the spores of bacillus subtilis 168: An effective mucosal vaccine candidate.pdf

黏膜疫苗研发

猪圆环病毒病防控

The oral mucosal vaccine has great potential in preventing a series of diseases caused by porcine circovirus type 2 (PCV2) infection. This study constructed a recombinant Bacillus subtilis RB with PCV

NIAID Data Ecosystem20

Chimeric Plant Virus Particles Administered Nasally or Orally Induce Systemic and Mucosal Immune Responses in Mice

黏膜疫苗研发

免疫应答评估

The humoral immune responses to the D2 peptide of fibronectin-binding protein B (FnBP) of Staphylococcus aureus, expressed on the plant virus cowpea mosaic virus (CPMV), were evaluated after mucosal d

PubMed Central20

A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern

黏膜疫苗研发

新冠病毒免疫

To develop a mucosal SARS-CoV-2 vaccine that can induce broad, durable protection, by expressing the six-proline-stabilized prefusion spikes from three diverse SARS-CoV-2 strains in the MeV, MuV-JL1,

Immunology Database and Analysis Portal2025-10-30 更新40

DataSheet_1_Induction of Mucosal IgA–Mediated Protective Immunity Against Nontypeable Haemophilus influenzae Infection by a Cationic Nanogel–Based P6 Nasal Vaccine.pdf

黏膜疫苗研发

非典型流感嗜血杆菌防治

Nontypeable Haemophilus influenzae (NTHi) strains form a major group of pathogenic bacteria that colonizes the nasopharynx and causes otitis media in young children. At present, there is no licensed v

NIAID Data Ecosystem20

Additional file 1 of Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection

资源简介：

相关数据集